Evidence map›Paper›PMID 39324650›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2024

Human Serum Albumin-Coated

Tianyuan Zhong, Yongjin Yang, Miao Pang, Yong Pan, Shiwei Jing, Yanxin Qi, Yubin Huang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Human Serum Albumin-CoatedAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Tianyuan ZhongFaculty of Chemistry, Northeast Normal University, Changchun, 130024, China.
Yongjin YangDepartment of Urology, The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, Gansu, 730000, China.
Miao PangFaculty of Chemistry, Northeast Normal University, Changchun, 130024, China.
Yong PanFaculty of Chemistry, Northeast Normal University, Changchun, 130024, China.
Shiwei JingSchool of Physics, Northeast Normal University, Changchun, 130024, China.
Yanxin QiFaculty of Chemistry, Northeast Normal University, Changchun, 130024, China.
Yubin HuangFaculty of Chemistry, Northeast Normal University, Changchun, 130024, China.ORCID 0000-0002-5212-318X

Funding

Fundamental Research Funds for the Central Universities 2412023QD017Fundamental Research Funds for the Central Universities-Excellent Youth Team Program 2412023YQ001National Natural Science Foundation of China 52103193National Natural Science Foundation of China 52273124Projects of Jilin Province Science and Technology Development Plan 20240101273JCShenzhen Science and Technology Program JCYJ20230807112801003
6 · The paper itself

Abstract

Boron neutron capture therapy (BNCT) is a physiologically focused radiation therapy that relies on nuclear capture and fission processes. BNCT is regarded as one of the most promising treatments due to its excellent accuracy, short duration of therapy, and low side effects. The creation of novel boron medicines with high selectivity, ease of delivery, and high boron-effective load is a current research topic. Herein, boron-containing carbon dots (BCDs) and their human serum albumin (HSA) complexes (BCDs-HSA) are designed and synthesized as boron-containing drugs for BNCT. BCDs (

Indexed as

BoronBoron Neutron Capture TherapyCarbonAnimalsBoron CompoundsDisease Models, AnimalHumansMiceQuantum DotsSerum Albumin, HumanBoronBoron CompoundsCarbonSerum Albumin, Humanboron‐containing carbon dotsboron neutron capture therapyhuman serum albumintumor targeting

Identifiers

PMID39324650
PMCPMC11578295

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.